1. Home
  2. FIVN vs XNCR Comparison

FIVN vs XNCR Comparison

Compare FIVN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five9 Inc.

FIVN

Five9 Inc.

HOLD

Current Price

$32.90

Market Cap

2.2B

Sector

Technology

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$27.59

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIVN
XNCR
Founded
2001
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
FIVN
XNCR
Price
$32.90
$27.59
Analyst Decision
Buy
Buy
Analyst Count
18
9
Target Price
$26.06
$22.33
AVG Volume (30 Days)
3.4M
1.1M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
364.71
65.36
EPS
0.25
N/A
Revenue
$1,149,088,000.00
$125,576,000.00
Revenue This Year
$11.39
N/A
Revenue Next Year
$10.00
$4.80
P/E Ratio
$129.20
N/A
Revenue Growth
10.28
13.65
52 Week Low
$13.29
$7.72
52 Week High
$34.58
$27.70

Technical Indicators

Market Signals
Indicator
FIVN
XNCR
Relative Strength Index (RSI) 61.21 79.96
Support Level $17.59 $11.05
Resistance Level $34.58 N/A
Average True Range (ATR) 2.01 1.32
MACD -0.10 0.48
Stochastic Oscillator 73.51 94.94

Price Performance

Historical Comparison
FIVN
XNCR

About FIVN Five9 Inc.

Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: